Log in
Enquire now
Vasopharm

Vasopharm

A company developing therapeutics for acute inflammatory central nervous system conditions

OverviewStructured DataIssuesContributors

Contents

vasopharm.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Pharmaceutical industry
Pharmaceutical industry
Engineering
Engineering
Technology
Technology
...
Location
Würzburg
Würzburg
0
Founder
‌
Ulrich Walter
0
‌
Harald Schmidt
0
AngelList URL
angel.co/vasopharm
Pitchbook URL
pitchbook.com/profiles.../57095-38
Email Address
office@vasopharm.com0
Phone Number
+4993135909900
Full Address
Friedrich-Bergius-Ring 15 97076 Wuerzburg / Germany0
Investors
‌
EF Investments
‌
Heidelberg Capital Private Equity
Bayern Kapital
Bayern Kapital
Entrepreneurs Fund
Entrepreneurs Fund
Future Capital
Future Capital
‌
Hanseatic Asset Management
‌
Ringtons Holdings
Fax Number
+49 (0)931 35 90 99-120
Total Funding Amount (USD)
35,000,000
Latest Funding Round Date
July 2019
Latest Funding Type
‌
Series F
Patents Assigned (Count)
1
Wellfound ID
vasopharm
Country
Germany
Germany
0

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Vasopharm

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.